Pharma, Medtech, and Biotech: Regulatory Updates, AI Risks, & Enforcement Trends
November 12, 20261:00–1:30 p.m. PT
Hot Topics in Regulatory, Privacy, and Compliance
Gardner Law Attorneys Nathan Downing, Paul Rothermel, and Amanda Johnston will open the program with three 10-minute briefings on timely regulatory, privacy, and compliance developments affecting medical products companies and their implications for legal and business priorities.
1:30–2:10 p.m. PT
Build:
Regulatory strategy, evidence, and product decisions
Moderator: Nathan Downing
Panelists: Dr. Cord Willhöft (Partner, Co-Head of Life Sciences & Healthcare, Fieldfisher), Alex Vayser (Founder, CEO, Concur Biophotonics & Founder, Videra Surgical), and Jeff Lau (Associate General Counsel, Glaukos)
Panelists will examine how companies navigate FDA and EU regulatory requirements, develop clinical evidence, and align product claims with intended use. The discussion will also address how data governance, privacy, cybersecurity, and early compliance decisions affect regulatory risk, commercialization, and investment or acquisition diligence.
2:10–2:50 p.m. PT
Launch:
Commercialization and marketplace risk
Moderator: Paul Rothermel
Panelists: Sameena Habib (Global R&D AI & Data Counsel, Medtronic), Chase Leavitt (General Counsel, Mobia Medical), and Brian Kelly (VP, Chief Compliance Officer, Advanced Bionics)
This panel will explore legal and operational risks associated with developing and commercializing AI-enabled technologies, evolving privacy requirements, promotional claims, reimbursement, and patient engagement. Panelists will also discuss managing data collection, sales practices, vendor oversight, and coordination across legal and business functions.
2:50–3:05 p.m. PT
Refreshment Break
3:05–3:45 p.m. PT
Grow:
Managing a more complex compliance environment
Moderator: Amanda Johnston
Panelists: Shannon Treviño (General Counsel, SpyGlass Pharma), Karyl Haskell (VP Regulatory Affairs and Quality Assurance, Orthalign), and Liana Edgar (Corporate Counsel, Heartflow)
As companies expand their products, markets, and commercial activities, regulatory and compliance obligations become increasingly complex. Panelists will discuss government enforcement priorities, healthcare fraud risks, internal investigations, and practical approaches to strengthening compliance programs through auditing, monitoring, third-party oversight, and internal controls.
3:45–4:15 p.m. PT
Ask the Experts: Regulatory, Privacy, and Compliance Q&A
Moderator: Mark Gardner
Panelists: Melissa Hoffman (Vice President, Lead Counsel: TMTT, Edwards Lifesciences), Christopher Shurland (Managing Counsel, Asahi Intecc USA), and Sara Kerrane (Vice President, Intellectual Property, Regulatory and Litigation Counsel, Glaukos Corporation)
The program will conclude with an interactive Q&A moderated by Mark Gardner. In-person and livestream attendees can submit questions to senior in-house attorneys about regulatory strategy, privacy, compliance, enforcement, and other legal and operational challenges facing medical products companies.
4:15 p.m. PT
Networking Reception
Certifications
The program has been submitted for approval for 3 CLE credits with the Minnesota and California State Bars and 3 RAC certification credits with the Regulatory Affairs Professional Society.
Contact
For questions about registration, livestream access, or continuing education credit, please email office@gardner.law.















